The oncogenic properties of G2A/GPR132 were also demonstrated in a study on fibroblasts [189], although there is no higher expression of G2A/GPR132 in GBM tumors than in healthy brain tissue [8,9]. This evidence concerns the gene GPR132 and glioblastoma.